Invasive Aspergillosis in Kidney Transplant Recipients: A Cohort Study

被引:11
|
作者
Jose Perez-Saez, Maria [1 ,4 ]
Mir, Marisa [1 ,4 ]
Milagro Montero, Maria [2 ,4 ]
Crespo, Marta [1 ,4 ]
Montero, Nuria [1 ,4 ]
Gomez, Julia [3 ,4 ]
Pablo Horcajada, Juan [2 ,4 ]
Pascual, Julio [1 ,4 ]
机构
[1] Hosp del Mar, Dept Nephrol, Barcelona 08003, Spain
[2] Hosp del Mar, Dept Infect Dis, Barcelona 08003, Spain
[3] Catalonian Reference Lab, Dept Microbiol, Barcelona, Spain
[4] Hosp del Mar, Med Res Inst, Barcelona 08003, Spain
关键词
Kidney transplant; Aspergillus; Invasive fungal infection; SOLID-ORGAN TRANSPLANTATION; HEMATOPOIETIC STEM-CELL; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; AMPHOTERICIN-B; RISK-FACTORS; EPIDEMIOLOGY; VORICONAZOLE; DIAGNOSIS; THERAPY;
D O I
10.6002/ect.2013.0205
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Objectives: Fungal infections represent 5% of infections in renal transplant recipients. Candidiasis is the most frequent, followed by aspergillosis and cryptococcosis. Invasive aspergillosis is severe and has a poor prognosis, but recent series focused on outcomes are scarce in the literature. We analyzed invasive aspergillosis cases in a cohort of kidney transplant recipients and suggest that prognosis is improved with early diagnosis and treatment. Patients and Methods: A retrospective study was performed in all kidney transplant undertaken in our hospital from January 1979 to December 2012. The incidence and characteristics of invasive aspergillosis were collected from kidney transplant prospective registry and microbiology laboratory. Results: We found 7 invasive aspergillosis cases (6 probable invasive aspergillosis and 1 possible invasive aspergillosis, according to EORTC/IFICG criteria); cumulative incidence 0.78% (7/891). The median posttransplant time until the disease onset was 3.03 months (interquartile range, 2.4-3.2 months), with a mean age of 56 years at the time of diagnosis. Six patients were male. Four patients had previous pulmonary disease. Six patients had received induction therapy (5 anti-IL2R antibodies, 1 with antilymphocytic antibodies). Two patients had received extra immunosuppression (1 with thymoglobulin to treat an acute rejection and the other 1 had a lymphoproliferative disorder and was on chemotherapy). Six patients were on calcineurin inhibitors at the time of diagnosis. Aspergillus fumigatus was the specimen most commonly isolated (6 cases). Six patients had a bacterial coinfection and 1 had a cytomegalovirus coinfection. All patients were treated with antifungal agents; 3 of which received voriconazole. Four patients satisfactorily resolved the episode and 3 died. Conclusions: Invasive aspergillosis incidence is low in kidney transplant although potentially lethal. We observed an acceptable survival of patients analyzed, better than usually reported. A high index of suspicion is essential to get an early diagnosis and start treatment.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [41] Invasive aspergillosis caused by cryptic species in transplant recipients: A review
    Kimura, Muneyoshi
    Husain, Shahid
    MEDICAL MYCOLOGY, 2025, 63 (02)
  • [42] Preventing invasive aspergillosis in hematopoietic stem cells transplant recipients
    Lamoth, Frederic
    Bochud, Pierre-Yves
    M S-MEDECINE SCIENCES, 2009, 25 (8-9): : 669 - 672
  • [43] Posttransplantation anemia in kidney transplant recipients A retrospective cohort study
    Gafter-Gvili, Anat
    Ayalon-Dangur, Irit
    Cooper, Lisa
    Shochat, Tzippy
    Rahamimov, Ruth
    Gafter, Uzi
    Mor, Eytan
    Grossman, Alon
    MEDICINE, 2017, 96 (32)
  • [44] Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis
    Butler-Laporte, Guillaume
    Langevin, Marie-Claude
    Lemieux, Claude
    Poirier, Charles
    Ferraro, Pasquale
    Theoret, Yves
    Me-Linh Luong
    CLINICAL TRANSPLANTATION, 2022, 36 (08)
  • [45] Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study
    Cordonnier, Catherine
    Rovira, Montserrat
    Maertens, Johan
    Olavarria, Eduardo
    Faucher, Catherine
    Bilger, Karin
    Pigneux, Arnaud
    Cornely, Oliver A.
    Ullmann, Andrew J.
    Bofarull, Rodrigo Martino
    de la Camara, Rafael
    Weisser, Maja
    Liakopoulou, Effie
    Abecasis, Manuel
    Heussel, Claus Peter
    Pineau, Marc
    Ljungman, Per
    Einsele, Hermann
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10): : 1762 - 1768
  • [46] Aspergillosis in Liver Transplant Recipients: A Single Center Experience
    Kim, Jong Man
    Kwon, Choon Hyuck David
    Joh, Jae-Won
    Song, Sanghyun
    Shin, Milljae
    Kim, Sung Joo
    Hong, Seung Heui
    Kim, Bok Nyeo
    Lee, Suk-Koo
    JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2010, 79 (04): : 267 - 274
  • [47] Invasive aspergillosis in patients with underlying liver cirrhosis: a prospective cohort study
    Prattes, Juergen
    Hoenigl, Martin
    Krause, Robert
    Buzina, Walter
    Valentin, Thomas
    Reischies, Frederike
    Koidl, Christoph
    Zollner-Schwetz, Ines
    MEDICAL MYCOLOGY, 2017, 55 (08) : 803 - 812
  • [48] Fatal outcome of disseminated invasive aspergillosis in kidney allograft recipients
    Keven, Kenan
    Sengul, Sule
    Memikoglu, Osman
    Soypacaci, Zeki
    Ustuner, Evren
    Cakmak, Atil
    Erbay, Bulent
    MEDICAL MYCOLOGY, 2008, 46 (07) : 713 - 717
  • [49] Immune reconstitution syndrome-like entity in lung transplant recipients with invasive aspergillosis
    Singh, Nina
    Suarez, Jose F.
    Avery, Robin
    Lass-Florl, Cornelia
    Geltner, Christian
    Pasqualotto, Alessandro C.
    Lyon, G. Marshall
    Barron, Michelle
    Husain, Shahid
    Wagener, Marilyn M.
    Montoya, Jose G.
    TRANSPLANT IMMUNOLOGY, 2013, 29 (1-4) : 109 - 113
  • [50] How We Approach Combination Antifungal Therapy for Invasive Aspergillosis and Mucormycosis in Transplant Recipients
    Haidar, Ghady
    Singh, Nina
    TRANSPLANTATION, 2018, 102 (11) : 1815 - 1823